GBM
Avastin gets GBM approval
June 18, 2013Research and Development, Sales and Marketing GBM, Roche, avastin
Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …
Glioblastoma vaccine enters phase II
February 24, 2011Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology
The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
Vaccine for brain cancer shows promise
June 3, 2010Research and Development Cancer, GBM, ImmunoCellular
Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …
Avastin approved for aggressive brain tumour
May 7, 2009Sales and Marketing GBM, avastin
Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
